Intravenous Interferon During the Anhepatic Phase of Liver Transplantation and Prevention of Recurrence of Hepatitis C Virus

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
American College of Gastroenterology
Information provided by (Responsible Party):
Mark W. Russo, Carolinas Healthcare System
ClinicalTrials.gov Identifier:
NCT01192698
First received: August 30, 2010
Last updated: September 17, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)